Fanconi Anemia: Fanconi anemia, breast and embryonal cancer risk revisited
نویسندگان
چکیده
منابع مشابه
Cancer in Fanconi anemia.
of CMV reactivation were reported by other groups using fludarabine in combination with busulphan, melphalan, or low-dose total body irradiation (TBI) (21%-42%). 5,6 The median time of onset of CMV infection was also beyond 45 days in all these studies. The only other regimen associated with a higher and earlier incidence of CMV infection has been a combination of fludarabine and antilymphocyte...
متن کاملFanconi anemia
What is it? Fanconi anemia (FA) is an autosomal recessive human disease characterized by congenital malformations, bone marrow failure and cancer. FA patients often develop leukemia and/or squamous cell carcinomas of the head and neck or gynecologic system. FA cells are hypersensitive to DNA crosslinking agents, such as mitomycin C (MMC) or diepoxybutane (DEB), and the syndrome is believed to r...
متن کاملFrequency of Hypothyroidism in Fanconi Anemia
Background: Fanconi anemia (FA) is a rare, autosomal recessive (AR) and multifactorial disorder. A high prevalence of FA observed in Iran is perhaps due to the high rate of consanguineous marriages. This study investigates the extent of short stature in patients with FA, the frequency of hypothyroidism in FA and the correlation between height and hypothyroidism. Methods: Eighteen patients with ...
متن کاملMutated Fanconi anemia pathway in non-Fanconi anemia cancers
An extremely high cancer incidence and the hypersensitivity to DNA crosslinking agents associated with Fanconi Anemia (FA) have marked it to be a unique genetic model system to study human cancer etiology and treatment, which has emerged an intense area of investigation in cancer research. However, there is limited information about the relationship between the mutated FA pathway and the cancer...
متن کاملB2/FANCN: Recombining Cancer and Fanconi Anemia
Downlo ner and localizer of BRCA2 (PALB2) was originally identified as a BRCA2-interacting protein that is l for key BRCA2 genome caretaker functions. It subsequently became clear that PALB2 was another ni anemia (FA) gene (FANCN), and that monoallelic PALB2 mutations are associated with increased risk st and pancreatic cancer. Mutations in PALB2 have been identified in breast cancer families w...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Journal of Human Genetics
سال: 2007
ISSN: 1018-4813,1476-5438
DOI: 10.1038/sj.ejhg.5201860